Patient Data Click to specify which aspects of the 0930 focused assessment indicate adverse reactions to albuterol. 0930: Albuterol given as prescribed via nebulizer. Following the treatment, decreased wheezes noted. The client's hands are trembling and is reporting a headache. Heart rate 129 beats/minute, respirations 20 breaths/minute, blood pressure 125/72 mm Hg, oxygen saturation 99% on room air.

Trembling: Trembling is a known side effect of albuterol due to its beta-2 adrenergic stimulation. Albuterol can cause fine muscle tremors, particularly in the hands, as part of its systemic sympathomimetic effects following inhalation. Headache: Headache can result from vasodilation and mild CNS stimulation caused by beta-agonists like albuterol. It is a frequently reported side effect and can occur even with appropriate dosing, particularly in sensitive individuals. Heart rate 129 beats/minute: Tachycardia is a common adverse effect of albuterol because it stimulates beta-1 receptors at higher doses, leading to an increased heart rate. A heart rate of 129 beats/minute post-treatment indicates a significant sympathetic response. Respirations 20 breaths/minute: A decrease in respiratory rate from 36 to 20 breaths/minute reflects clinical improvement in respiratory distress. It is a positive response to albuterol therapy, not an adverse reaction. Oxygen saturation 99% on room air: Improvement of oxygen saturation from 83% to 99% is a therapeutic goal with bronchodilator use. This indicates better gas exchange after albuterol treatment and is not an adverse reaction.